Applied dna and the cornell university college of veterinary medicine announce research collaboration to accelerate application of lineardna™ platform for veterinary health applications

Stony brook, n.y. & ithica, n.y.--(business wire)---- $apdn #cucvm--applied dna sciences, inc. (nasdaq: apdn) (‘applied dna' or the “company”), a leader in polymerase chain reaction ("pcr")-based technologies, and the cornell university college of veterinary medicine (“cucvm”) announced the signing of a research agreement (the “agreement”) to advance lineardna™-based vaccine research and discovery for animal diseases with agricultural biosecurity implications. primarily, the agreement seeks to combine lineardna
APDN Ratings Summary
APDN Quant Ranking